Lupus Ventures takes stake in Glycostem

2018: Momentum continues to build in advance of Glycostem’s pivotal 2019 trials.

Please click here to open Lupus Venture news.

Subscribe to our newsletter

If you subscribe you agree to the Privacy Notice of Glycostem Therapeutics B.V. as found on the website.